It was suggested that PAX2 and PAX5 play tumor suppressor roles in ovarian cancer and leukemia47,48, while conversely, PAX3, PAX7, and PAX6 were reported to be oncogenic in embryonal rhabdomyosarcomas and retinoblastoma49,50. This evidence concerns the gene PAX5 and embryonal rhabdomyosarcoma.